Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes

Hormone and Metabolic Research

Volumn 39, Issue 11, 2007, Pages 781-789

  Sigruener, A ^a   Buechler, C ^a   Orso E ^a   Hartmann, A ^a   Wild, P J ^b   Terracciano, L ^c   Roncalli, M ^d   Bornstein, S R ^e   Schmitz, C ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF MILAN   (Italy)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

ABCA1; AOX1; Efflux; HepG2; siRNA

Indexed keywords

ABC TRANSPORTER A1; ALDEHYDE OXIDASE; ALDEHYDE OXIDASE 1; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; ARTICLE; CANCER STAGING; CELL FUNCTION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; LEYDIG CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METASTASIS; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TISSUE MICROARRAY; UPREGULATION;

ALDEHYDE OXIDASE; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FATTY ACIDS; GENE LIBRARY; GENE SILENCING; HEPATOCYTES; HUMANS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TISSUE DISTRIBUTION;

EID: 36749030043     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992129     Document Type: Article

References (55)

1. Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000; 275: 33053-33058
2. Bodzioch M, Orso E, Klucken J, Langmann T, Boettcher A, Diederich W, Drobnik W, Barlage S, Buechler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22: 347-351
3. Munehira Y, Ohnishi T, Kawamoto S, Furuya A, Shitara K, Imamura M, Yokota T, Takeda S, Amachi T, Matsuo M, Kioka N, Ueda K. Alpha1-syntrophin modulates turnover of ABCA1. J Biol Chem 2004; 279: 15091-15095
4. Okuhira K, Fitzgerald ML, Sarracino DA, Manning JJ, Bell SA, Goss JL, Freeman MW. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. J Biol Chem 2005; 280: 39653-39664
5. Buechler C, Boettcher A, Bared SM, Probst MC, Schmitz G. The carboxy-terminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. Biochem Biophys Res Commun 2002; 293: 759-765
6. Buechler C, Bared SM, Aslanidis C, Ritter M, Drobnik W, Schmitz G. Molecular and functional interaction of the ATP-binding cassette transporter Al with Fas-associated death domain protein. J Biol Chem 2002; 277: 41307-41310
7. Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, Eckardstein A von, Assmann G. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 2006; 47: 794-803
8. Hirano K, Matsuura F, Tsukamoto K, Zhang Z, Matsuyama A, Takaishi K, Komuro R, Suehiro T, Yamashita S, Takai Y, Matsuzawa Y. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux. FEBS Lett 2000; 484: 275-279
9. Nofer JR, Feuerborn R, Levkau B, Sokoll A, Seedorf U, Assmann G. Involvement of Cdc42 signaling in apoA-1-induced cholesterol efflux. J Biol Chem 2003; 278: 53055-53062
10. Engel T, Lueken A, Bode G, Hobohm U, Lorkowski S, Schlueter B, Rust S, Cullen P, Pech M, Assmann G, Seedorf U. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett 2004; 566: 241-246
11. Bared SM, Buechler C, Boettcher A, Dayoub R, Sigruener A, Grandi M, Rudolph C, Dada A, Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. Mol Biol Cell 2004; 15: 5399-5407
12. Garattini E, Mendel R, Romao MJ, Wright R, Terao M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem J 2003; 372: 15-32
13. Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Hada T. Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining. Histol Histopathol 2001; 16: 745-753
14. Obach RS. Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 2004; 32: 89-97
15. Obach RS, Huynh P, Allen MC, Beedham C. Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 2004; 44: 7-19
16. Moriwaki Y, Yamamoto T, Higashino K. Distribution and pathophysiologic role of molybdenum-containing enzymes. Histol Histopathol 1997; 12: 513-524
17. Shaw S, Jayatilleke E. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat. Biochem J 1990; 268: 579-583
18. Wright RM, MacManaman JL, Repine JE. Alcohol-induced breast cancer: a proposed mechanism. Free Radic Biol Med 1999; 26: 348-354
19. Tomita S, Tsujita M, Ichikawa Y. Retinal oxidase is identical to aldehyde oxidase. FEBS Lett 1993; 336: 272-274
20. Huang DY, Ichikawa Y. Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol. Biochem Biophys Res Commun 1994; 205: 1278-1283
21. Colakoglu N, Kukner A, Oner J, Sonmez MF, Oner H, Ozan E. Effects of high dose retinoic acid on TGF-beta2 expression during pancreatic organogenesis. J Mol Histol 2005; 36: 413-418
22. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, Costello E, Neoptolemos J, Lemoine NR. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005; 129: 1454-1463
23. Vendrov AE, Madamanchi NR, Hakim ZS, Rojas M, Runge MS. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res 2006; 98: 1254-1263
24. Langmann T, Mauerer R, Zahn A, Moehle C, Probst M, Stremmel W, Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem 2003; 49: 230-238
25. Drobnik W, Borsukova H, Boettcher A, Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 2002; 3: 268-278
26. Dini L, Lentini A, Diez GD, Rocha M, Falasca L, Serafino L, Vidal-Vanaclocha F. Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci 1995; 108 (Pt 3): 967-973
27. Zha X, Genest Jr J, MacPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport. J Biol Chem 2001; 276: 39476-39483
28. Zha X, Gauthier A, Genest J, MacPherson R. Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux. J Biol Chem 2003; 278: 10002-10005
29. Bondy SC, Orozco J. Effects of ethanol treatment upon sources of reactive oxygen species in brain and liver. Alcohol Alcohol 1994; 29: 375-383
30. Shaw S, Jayatilleke E. The role of cellular oxidases and catalytic iron in the pathogenesis of ethanol-induced liver injury. Life Sci 1992; 50: 2045-2052
31. Shaw S, Jayatilleke E. Cimetidine as a scavenger of ethanol-induced free radicals. Alcohol 1992; 9: 363-367
32. Shaw S, Eng J, Jayatilleke E. Ethanol-induced free radical injury to the hepatocyte glucagon receptor. Alcohol 1995; 12: 273-277
33. Wright RM, Riley MG, Weigel LK, Ginger LA, Costantino DA, MacManaman JL. Activation of the human aldehyde oxidase (hAOX1) promoter by tandem cooperative Sp1/Sp3 binding sites: identification of complex architecture in the hAOX upstream DNA that includes a proximal promoter, distal activation sites, and a silencer element. DNA Cell Biol 2000; 19: 459-474
34. Mira L, Maia L, Barreira L, Manso CF. Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism. Arch Biochem Biophys 1995; 318: 53-58
35. Wright RM, Weigel LK, Repine JE. Aldehyde oxidase generates deoxyribonucleic acid single strand nicks in vitro. Redox Rep 1995; 1: 313-321
36. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501
37. Babior BM. NADPH oxidase. Curr Opin Immunol 2004; 16: 42-47
38. Wang Y, Zeigler MM, Lam CK, Hunter MG, Eubank TD, Khramtsov VV, Tridandapani SV, Sen CK, Marsh CB. The Role of the NADPH Oxidase Complex, p38 MAPK and Akt in Regulating Human Monocyte/Macrophage Survival. Am J Respir Cell Mol Biol 2007; 36: 68-77
39. Nagao S, Murao K, Imachi H, Cao WM, Yu X, Li J, Matsumoto K, Nishiuchi T, Ahmed RA, Wong NC, Ueda K, Ishida T. Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett 2006; 580: 4371-4376
40. Landry YD, Denis M, Nandi S, Bell S, Vaughan AM, Zha X. ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem 2006; 281: 36091-36101
41. Nofer JR, Giet M van der, Tolle M, Wolinska I, Wnuck LK von, Baba HA, Tietge UJ, Godecke A, Ishii I, Kleuser B, Schafers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S. 1P3. J Clin Invest 2004; 113: 569-581
42. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523-1528
43. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 1977; 2: 153-155
44. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987; 126: 629-637
45. Beulens JW, Sierksma A, Tol A van, Fournier N, Gent T van, Paul JL, Hendriks HF. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1. J Lipid Res 2004; 45: 1716-1723
46. Wang XD. Alcohol, vitamin A, and cancer. Alcohol 2005; 35: 251-258
47. Terao M, Kurosaki M, Barzago MM, Varasano E, Boldetti A, Bastone A, Fratelli M, Garattini E. Avian and canine aldehyde oxidases: novel insights into the biology and evolution of molybdo-flavoenzymes. J Biol Chem 2006; 281: 19748-19761
48. Langmann T, Liebisch G, Moehle C, Schifferer R, Dayoub R, Heiduczek S, Grandi M, Dada A, Schmitz G. Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim Biophys Acta 2005; 1740: 155-161
49. Beedham C, Miceli JJ, Obach RS. Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Clin Psychopharmacol 2003; 23: 229-232
50. Brown RR, Estoup MW. Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine. Int Clin Psychopharmacol 2005; 20: 105-112
51. Yang YM, Huang DY, Liu GF, Zhong JC, Du K, Li YF, Song XH. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice. J Biochem Mol Toxicol 2005; 19: 327-335
52. Shaban Z, El-Shazly S, Abdelhady S, Fattouh I, Muzandu K, Ishizuka M, Kimura K, Kazusaka A, Fujita S. Down regulation of hepatic PPARalpha function by AhR ligand. J Vet Med Sci 2004; 66: 1377-1386
53. Neumeier M, Weigert J, Schaffler A, Weiss TS, Schmidl C, Buttner R, Bollheimer C, Aslanidis C, Scholmerich J, Buechler C. Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. Biochem Biophys Res Commun 2006; 350: 731-735
54. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001; 7: 53-58
55. Selva DM, Hirsch-Reinshagen V, Burgess B, Zhou S, Chan J, MacIsaac S, Hayden MR, Hammond GL, Vogl AW, Wellington CL. The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility. J Lipid Res 2004; 45: 1040-1050